"Hamartoma" of the spleen (splenoma) in children

Carlos Abramowsky1, Carlos Alvarado, J Bradley Wyly

  • 1Department of Pathology, Emory University School of Medicine, Egleston Children's Hospital, 1405 Clifton Road, Atlanta, GA 30322, USA. cabramo@emory.edu

Insights

Pediatric splenomas, uncommon splenic growths, are often linked to hematologic disorders. Splenectomy improved blood values in four young patients, suggesting splenomas are a fibro-inflammatory reaction, not true hamartomas.

Area of Science:

  • Pediatric Pathology
  • Hematology
  • Surgical Oncology

Background:

  • Splenic hamartomas (splenomas) are rare benign splenic tumors, poorly characterized in pediatric populations.
  • These growths are often associated with various hematologic conditions, impacting spleen function and patient health.

Purpose of the Study:

  • To characterize the clinicopathologic features of splenic "hamartomas" in children.
  • To investigate the relationship between these splenic lesions and underlying hematologic disorders.
  • To evaluate the therapeutic outcome of splenectomy in affected pediatric patients.

Main Methods:

  • Retrospective analysis of four pediatric patients (ages 4-11) with splenomegaly and splenic nodules.
  • Review of clinical data, imaging studies (CT, MRI, ultrasonography), and histopathologic findings.
  • Histologic examination included assessment of cellular proliferation (Ki-67) and reticulin staining.

Main Results:

  • Four pediatric patients presented with splenomegaly and splenic nodules associated with diverse hematologic conditions.
  • Histology revealed red pulp alterations with fibro-inflammatory changes, extramedullary hematopoiesis, and siderotic deposits, lacking a capsule.
  • Low Ki-67 proliferation index (<5%) was observed in both nodules and surrounding splenic tissue.

Conclusions:

  • Splenic nodules in children with hematologic disorders are likely splenomas, representing a reactive fibro-inflammatory process rather than true hamartomas.
  • These lesions are associated with underlying hematologic conditions and hypersplenism.
  • Splenectomy is an effective therapeutic approach, leading to significant improvement in hematologic parameters post-operatively.

Related Concept Videos

Overview of Hematopoiesis01:20

Overview of Hematopoiesis

Hematopoiesis, or blood cell production, is a vital biological process that begins early in embryonic development and continues throughout life. This process generates the various types of cells found in blood, including red blood cells, white blood cells, and platelets from hematopoietic stem cells (HSCs).
Developmental Phases of Hematopoiesis
Initially, HSCs are formed in the embryonic yolk sac, a critical site for early blood cell production. These stem cells subsequently migrate to other...
Bone Marrow Sampling and Transplants01:22

Bone Marrow Sampling and Transplants

Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...
Multipotency of Hematopoietic Stem Cells01:19

Multipotency of Hematopoietic Stem Cells

The hematopoietic stem cells or HSCs are multipotent, meaning they can differentiate and give rise to all blood and immune cells. HSCs are maintained in the quiescent stage until an external stimulus initiates their differentiation. The multipotent HSCs exist as two heterogeneous populations, long-term repopulating cells (LTRC) and short-term repopulating cells (STRC). The two HSC populations have different surface markers or receptors and are classified based on quiescence and long-term...